COVID-19 Paediatric VLA2001-321 Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Randomized, Double-blinded, Active-controlled Study to evaluate the Safety, Tolerability and Immunogenicity of VLA2001 in participants of ≥2 to 12 years. In total 1720 participants will receive either VLA2001 or active Comparator.
Epistemonikos ID: a29c0fc922a8dedf073eb4668eda076c193f43c5
First added on: Mar 29, 2022